Investment Trusts

Life Science REIT PLC

LABS:LSE

Life Science REIT PLC

Actions
  • Price (GBX)34.60
  • Today's Change-0.600 / -1.70%
  • Shares traded1.70m
  • 1 Year change-52.60%
  • Beta--
Data delayed at least 20 minutes, as of May 24 2024 08:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceLife Science REIT PLC (Ordinary Share)-48.72%
NAVLife Science REIT PLC (Ordinary Share)-7.69%
Morningstar's BenchmarkNo benchmark--

Key statistics

Life Science REIT PLC (LABS:LSE) set a new 52-week low during today's trading session when it reached 34.30. Over this period, the share price is down -53.24%.
52-week range
Today
34.30May 24 202477.40Jun 14 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding350.00m
Market cap125.30m GBP
Total assets283.12m GBP
Total expense ratio1.79%
High35.10
Low34.30
Previous close35.20
Average volume1.89m
YTD Change-45.25%
Beta--
Diluted NAV (est)80.90
Diluted NAV (last pub)81.10
Premium/Discount-56.49%
Net Gearing0.00%
Annual div (ADY)2.00
GBX
Annual div yield (ADY)5.59%
Div ex-dateApr 04 2024
Div pay-dateMay 13 2024
Data delayed at least 20 minutes, as of May 24 2024 08:46 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.